
  
    
      
        Introduction_NNP
        Breast_NNP cancer_NN is_VBZ a_DT major_JJ cause_NN of_IN death_NN among_IN women_NNS in_IN
        the_DT United_NNP States_NNPS and_CC worldwide_NN [_NN 1_CD ]_NN ._. While_IN cures_NNS are_VBP
        probable_JJ if_IN the_DT cancer_NN is_VBZ detected_VBN early_JJ and_CC remains_VBZ
        localized_VBN ,_, many_JJ patients_NNS will_MD succumb_NN to_TO the_DT disease_NN if_IN the_DT
        primary_JJ tumor_NN metastasizes_NNS to_TO secondary_JJ organs_NNS ._. Although_IN
        significant_JJ progress_NN has_VBZ been_VBN made_VBN in_IN detecting_VBG and_CC
        treating_VBG the_DT primary_JJ tumor_NN ,_, the_DT ability_NN to_TO predict_VB the_DT
        metastatic_JJ behavior_NN of_IN a_DT patient_NN 's_POS tumor_NN and_CC to_TO eradicate_VB
        or_CC control_VB recurrent_JJ disseminated_VBN malignancy_NN remain_VB major_JJ
        clinical_JJ challenges_NNS in_IN oncology_NN ._.
        We_PRP have_VBP previously_RB characterized_VBN an_DT experimental_JJ system_NN
        that_WDT enables_VBZ comparative_JJ molecular_JJ screening_NN and_CC functional_JJ
        evaluation_NN of_IN candidate_NN breast_NN metastasis-related_JJ genes_NNS in_IN
        an_DT isogenic_JJ background_NN [_NN 2_CD ]_NN ._. Two_CD independent_JJ clones_NNS of_IN
        opposing_VBG metastatic_JJ phenotype_NN were_VBD derived_VBN from_IN the_DT
        MDA-MB-_NNP 435_CD breast_NN tumor_NN cell_NN line_NN (_( metasatic_JJ M-_NNP 4_CD A_DT 4_CD and_CC
        nonmetastatic_JJ NM-_NNP 2_CD C_NNP 5_CD cell_NN lines_NNS )_) ._. When_WRB inoculated_JJ into_IN the_DT
        mammary_JJ fat_JJ pad_NN of_IN athymic_JJ mice_NNS ,_, both_DT cell_NN lines_NNS form_VBP
        primary_JJ tumors_NNS ._. While_IN clone_NN M-_NNP 4_CD A_DT 4_CD aggressively_RB metastasizes_NNS
        to_TO the_DT lung_NN and_CC lymph_NN nodes_NNS ,_, the_DT NM-_NNP 2_CD C_NNP 5_CD clone_NN is_VBZ entirely_RB
        nonmetastatic_JJ ._. Initial_JJ comparative_JJ gene_NN expression_NN analysis_NN
        of_IN the_DT two_CD clones_NNS revealed_VBD the_DT secreted_JJ ,_, integrin-binding_JJ
        protein_NN osteopontin_NN (_( OPN_NNP )_) [_NN 3_CD ]_NN to_TO be_VB significantly_RB
        increased_VBN in_IN the_DT metastatic_JJ M-_NNP 4_CD A_DT 4_CD cell_NN line_NN ._. Conversely_RB ,_,
        the_DT expression_NN of_IN thrombospondin-_NN 1_CD (_( TSP-_NNP 1_LS )_) [_NN 4_CD ]_NN and_CC of_IN
        tyrosinase-related_JJ protein-_NN 1_CD (_( TYRP-_NNP 1_LS )_) was_VBD markedly_RB
        overexpressed_JJ in_IN the_DT nonmetastatic_JJ NM-_NNP 2_CD C_NNP 5_CD cell_NN line_NN [_NN 2_CD 5_CD ]_NN
        ._.
        OPN_NNP is_VBZ a_DT secreted_JJ glycophosphoprotein_NN expressed_VBN by_IN a_DT
        number_NN of_IN cell_NN types_NNS ,_, including_VBG leukocytes_NNS and_CC epithelial_NN
        lineages_NNS ,_, and_CC it_PRP has_VBZ been_VBN implicated_VBN biologically_RB in_IN bone_NN
        development_NN ,_, in_IN immune_JJ system_NN regulation_NN [_NN 6_CD ]_NN ,_, and_CC in_IN
        multiple_JJ mechanisms_NNS through_IN signal_NN transduction_NN via_IN its_PRP$
        binding_JJ to_TO integrins_NNS [_NN 7_CD ]_NN ._. OPN_NNP has_VBZ been_VBN detected_VBN in_IN
        primary_JJ breast_NN tumors_NNS and_CC is_VBZ elevated_VBD in_IN the_DT plasma_NN of_IN
        patients_NNS with_IN metastatic_JJ breast_NN cancer_NN [_NN 8_CD 9_CD ]_NN ,_, but_CC an_DT
        association_NN between_IN elevated_VBD levels_NNS of_IN primary_JJ tumor_NN OPN_NNP
        and_CC metastatic_JJ burden_NN has_VBZ not_RB been_VBN well_RB established_VBN ._.
        TSP-_NNP 1_CD is_VBZ a_DT homotrimeric_JJ multidomain_NN glycoprotein_NN
        synthesized_JJ and_CC secreted_JJ by_IN numerous_JJ cell_NN types_NNS ,_, including_VBG
        platelets_NNS ,_, vascular_NN smooth_JJ muscle_NN cells_NNS and_CC keratinocytes_NNS [_NN
        4_CD ]_NN ._. Due_JJ to_TO its_PRP$ interaction_NN with_IN a_DT wide_JJ variety_NN of_IN
        proteins_NNS ,_, TSP-_NNP 1_CD has_VBZ been_VBN implicated_VBN in_IN a_DT number_NN of_IN
        biological_JJ processes_VBZ including_VBG coagulation_NN ,_, cell_NN adhesion_NN ,_,
        the_DT modulation_NN of_IN cell-cell_JJ and_CC cell-matrix_JJ interactions_NNS ,_,
        control_NN of_IN tumor_NN growth_NN and_CC metastasis_NNS ,_, and_CC angiogenesis_NNS [_NN
        10_CD ]_NN ._. Inhibition_NNP of_IN tumor_NN cell_NN proliferation_NN has_VBZ been_VBN
        achieved_VBN 
        in_IN vivo_NN by_IN systemic_JJ treatment_NN with_IN
        TSP-_NNP 1_CD peptide_NN mimetics_NNS [_NN 11_CD ]_NN ,_, but_CC a_DT correlation_NN between_IN
        primary_JJ tumor_NN TSP-_NNP 1_CD expression_NN and_CC poor_JJ prognosis_NN has_VBZ not_RB
        been_VBN clearly_RB established_VBN [_NN 12_CD ]_NN ._. While_IN there_EX are_VBP reports_NNS
        that_IN these_DT molecules_NNS can_MD originate_VB from_IN tumor_NN cells_NNS [_NN 13_CD ]_NN
        ,_, the_DT majority_NN of_IN reports_NNS have_VBP suggested_VBN that_IN the_DT major_JJ
        source_NN of_IN both_DT TSP-_NNP 1_CD and_CC OPN_NNP is_VBZ tumor-associated_JJ stroma_NN [_NN
        14_CD ]_NN or_CC infiltrating_VBG macrophages_NNS and_CC lymphocytes_NNS [_NN 15_CD ]_NN
        ._.
        The_DT melanogenic_JJ enzymes_NNS TYRP-_NNP 1_CD and_CC TYRP-_NNP 2_CD are_VBP
        well-characterized_JJ differentiation_NN antigens_NNS recognized_VBN by_IN
        antibodies_NNS and_CC T_NN cells_NNS of_IN patients_NNS with_IN melanoma_NN [_NN 16_CD ]_NN ._.
        The_DT evaluation_NN of_IN TYRP-_NNP 1_CD expression_NN in_IN human_JJ breast_NN lesions_NNS
        has_VBZ not_RB been_VBN documented_VBN to_TO date_NN ._.
        The_DT aim_NN of_IN the_DT present_JJ work_NN was_VBD to_TO examine_VB the_DT cellular_JJ
        distribution_NN of_IN OPN_NNP ,_, of_IN TSP-_NNP 1_CD and_CC of_IN TYRP-_NNP 1_CD in_IN human_JJ breast_NN
        tissue_NN ,_, and_CC to_TO determine_VB whether_IN the_DT relative_JJ expression_NN
        level_NN of_IN these_DT three_CD genes_NNS was_VBD associated_VBN with_IN malignancy_NN
        or_CC breast_NN tumor_NN metastasis_NNS ._. To_TO overcome_VB the_DT problem_NN of_IN
        heterogeneity_NN and_CC stromal_NN cell_NN contamination_NN in_IN homogenized_JJ
        tissue_NN specimens_NNS ,_, specific_JJ cell_NN types_NNS were_VBD isolated_VBN by_IN
        laser_NN capture_NN microdissection_NN (_( LCM_NNP )_) prior_RB to_TO analysis_NN ._. We_PRP
        used_VBD a_DT combination_NN of_IN immunohistochemistry_NN (_( IHC_NNP )_) ,_, LCM_NNP and_CC
        real-time_JJ ,_, quantitative_JJ PCR_NNP (_( qPCR_NN )_) analysis_NN of_IN material_NN
        obtained_VBN from_IN a_DT panel_NN of_IN primary_JJ breast_NN infiltrating_VBG ductal_NN
        carcinomas_NNS and_CC nodal_NN metastases_NNS ,_, and_CC compared_VBD the_DT target_NN
        gene_NN expression_NN levels_NNS with_IN those_DT found_VBN in_IN nonmalignant_NN
        diseased_JJ tissue_NN and_CC in_IN samples_NNS of_IN normal_JJ breast_NN tissue_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Tissue_NNP samples_NNS
          Sixty-eight_NNP frozen_VBN human_JJ breast_NN tissue_NN specimens_NNS were_VBD
          evaluated_VBN by_IN LCM_NNP ,_, qPCR_NN and_CC IHC_NNP ,_, including_VBG 31_CD primary_JJ
          tumors_NNS of_IN infiltrating_VBG ductal_NN carcinomas_NNS (_( 22_CD primary_JJ
          tumors_NNS with_IN metastasis_NNS and_CC nine_CD primary_JJ tumors_NNS without_IN
          known_VBN metastasis_NNS )_) ,_, 22_CD matched_VBN nodal_NN metastases_NNS ,_, 10_CD
          fibroadenomas_NNS and_CC five_CD normal_JJ breast_NN tissues_NNS (_( obtained_VBN
          from_IN reduction_NN mammoplasty_NN )_) ._. In_IN addition_NN ,_, eight_CD
          tumor-associated_JJ stromal_NN components_NNS (_( including_VBG
          fibroblasts_NNS ,_, endothelial_NN cells_NNS and_CC inflammatory_JJ cells_NNS )_)
          were_VBD microdissected_JJ from_IN primary_JJ tumors_NNS without_IN known_VBN
          metastases_NNS for_IN analysis_NN ._.
          Breast_NNP tissues_NNS were_VBD obtained_VBN from_IN surgical_JJ specimens_NNS
          at_IN the_DT John_NNP Radcliffe_NNP Hospital_NNP ,_, Oxford_NNP ,_, UK_NNP and_CC at_IN the_DT
          UCSD_NNP Medical_NNP Center_NNP ._. Samples_NNP were_VBD obtained_VBN in_IN random_JJ
          order_NN from_IN the_DT residue_NN of_IN tissue_NN used_VBN for_IN pathological_JJ
          diagnosis_NN that_WDT would_MD otherwise_RB have_VB been_VBN discarded_VBN ._.
          Tissues_NNPS were_VBD snap-frozen_JJ immediately_RB after_IN resection_NN and_CC
          were_VBD stored_VBN in_IN liquid_JJ nitrogen_NN until_IN analysis_NN ._. Four_CD pairs_NNS
          of_IN additional_JJ formalin-fixed_JJ ,_, paraffin-embedded_JJ (_( FFPE_NNP )_)
          specimens_NNS of_IN primary_JJ infiltrating_VBG ductal_NN carcinomas_NNS and_CC
          of_IN matched_VBN nodal_NN metastasis_NNS were_VBD also_RB used_VBN for_IN IHC_NNP only_RB
          (_( total_NN of_IN 76_CD samples_NNS for_IN IHC_NNP )_) ._. Histological_NNP diagnosis_NN of_IN
          all_DT samples_NNS was_VBD performed_VBN using_VBG H_NNP &_CC E-_NNP stained_JJ cryostat_NN
          sections_NNS (_( JWR_NNP )_) ._. The_DT histological_JJ grade_NN was_VBD assigned_VBN
          according_VBG to_TO the_DT modified_VBN Bloom-_NNP Richardson_NNP grading_VBG scheme_NN
          [_NN 17_CD ]_NN ._. Tissue_NNP samples_NNS were_VBD obtained_VBN and_CC processed_VBN under_IN
          approval_NN of_IN the_DT UCSD_NNP Institutional_NNP Review_NNP Board_NNP for_IN
          studying_VBG existing_VBG tissues_NNS (_( #_# 011246_CD X_NNP )_) ._.
        
        
          Laser_NNP capture_VB microdissection_NN
          The_DT total_JJ number_NN of_IN samples_NNS studied_VBD using_VBG LCM_NNP and_CC qPCR_NN
          were_VBD 76_CD (_( 68_CD samples_NNS were_VBD microdissected_JJ to_TO specifically_RB
          enrich_VBP for_IN cells_NNS of_IN epithelial_NN origin_NN ,_, and_CC eight_CD samples_NNS
          were_VBD microdissected_JJ to_TO obtain_VB tumor-associated_JJ stroma_NN )_) ._.
          Frozen_NNP tissues_NNS were_VBD embedded_VBN in_IN Optimal_NNP Cutting_VBG
          Temperature_NNP Compound_NN (_( OCT_NNP ;_: Sakura_NNP Finetek_NNP ,_, Torrance_NNP ,_, CA_NNP ,_,
          USA_NNP )_) and_CC held_VBN at_IN -_: 70_CD °_NN C_NNP prior_RB to_TO sectioning_VBG ._.
          Five-micrometer_NNP cryosections_NNS were_VBD mounted_VBN onto_IN uncoated_JJ
          microscope_NN slides_NNS ,_, immediately_RB fixed_VBN by_IN immersion_NN in_IN
          acetone_NN for_IN 30_CD s_VBZ and_CC washed_VBN with_IN RNAse-free_NNP water_NN ._.
          Staining_NNP with_IN H_NNP &_CC E_NNP (_( Sigma_NNP ,_, St_NNP Louis_NNP ,_, MO_NNP ,_, USA_NNP )_) for_IN 1_CD
          min_NN was_VBD performed_VBN for_IN morphological_JJ evaluation_NN ._. After_IN
          dehydration_NN in_IN 95_CD %_NN ethanol_NN twice_RB for_IN 1_CD min_NN and_CC in_IN 100_CD %_NN
          ethanol_NN for_IN 1_CD min_NN ,_, sections_NNS were_VBD cleared_VBN in_IN xylene_NN for_IN 2_CD
          min_NN and_CC were_VBD air-dried_JJ ._. LCM_NNP was_VBD performed_VBN with_IN the_DT
          PixCell_NNP I_PRP LCM_NNP System_NNP (_( Arcturus_NNP Engineering_NNP ,_, Mountain_NNP
          View_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. Following_VBG the_DT manufacturer_NN 's_POS protocols_NNS ,_,
          approximately_RB 2_CD -_: 5000_CD cell_NN equivalents_NNS were_VBD dissected_VBN from_IN
          each_DT slide_NN for_IN subsequent_JJ analysis_NN ._.
        
        
          RNA_NNP extraction_NN and_CC cDNA_NN synthesis_NN
          Total_NNP RNA_NNP was_VBD extracted_VBN from_IN frozen_VBN breast_NN tissues_NNS and_CC
          laser-captured_JJ materials_NNS using_VBG the_DT StrataPrep_NNP Total_NNP RNA_NNP
          kit_NN (_( Stratagene_NNP ,_, La_NNP Jolla_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. All_DT samples_NNS were_VBD
          DNase-treated_NNP to_TO remove_VB contaminating_VBG DNA_NNP and_CC the_DT yield_NN
          was_VBD measured_VBN spectrophotometrically_RB ._. Single-stranded_NNP cDNA_NN
          was_VBD synthesized_JJ from_IN total_JJ RNA_NNP using_VBG MMLV_NNP reverse_VB
          transcriptase_NN (_( Retroscript_NNP RT_NNP kit_NN ;_: Ambion_NNP ,_, Inc_NNP ._. ,_, Austin_NNP ,_,
          TX_NNP ,_, USA_NNP )_) ._.
        
        
          Real-time_NNP ,_, quantitative_JJ PCR_NNP
          Primer_NNP sets_NNS for_IN OPN_NNP ,_, TSP-_NNP 1_CD ,_, TYRP-_NNP 1_CD and_CC
          glyceraldehyde-_NN 3_CD -_: phosphate-dehydrogenase_JJ (_( GAPDH_NNP ,_, the_DT
          housekeeping_NN gene_NN )_) were_VBD designed_VBN using_VBG Primer_NNP Express_NNP
          Version_NNP 1_CD ._. 5_CD software_NN (_( Applied_NNP Biosystems_NNP ,_, Foster_NNP City_NNP ,_,
          CA_NNP ,_, USA_NNP )_) ._. The_DT qPCR_NN was_VBD performed_VBN on_IN an_DT Applied_NNP Biosystems_NNP
          PRISM_NNP 7700_CD Sequence_NNP Detection_NNP System_NNP using_VBG SYBR_NNP Green_NNP ®_NN I_PRP
          chemistry_NN ._. Sequence_NNP Detection_NNP Software_NNP version_NN 1_CD ._. 7_CD was_VBD
          applied_VBN to_TO data_NNS collection_NN and_CC analyses_NNS (_( Applied_NNP
          Biosystems_NNP )_) ._.
          The_DT optimal_NN primer_NN concentrations_NNS for_IN the_DT reference_NN
          and_CC target_NN genes_NNS in_IN the_DT final_JJ PCR_NNP reaction_NN were_VBD
          determined_VBN ,_, and_CC both_DT dissociation_NN curves_NNS (_( ABI_NNP
          Dissociation_NNP Curves_NNP version_NN 1_CD ._. 0_CD software_NN ;_: Applied_NNP
          Biosystems_NNP ,_, Foster_NNP City_NNP ,_, CA_NNP ,_, USA_NNP )_) and_CC agarose_NN gel_NN
          electrophoretic_JJ analyses_NNS were_VBD applied_VBN to_TO confirm_VB the_DT
          specificity_NN of_IN PCR_NNP products_NNS and_CC to_TO check_VB for_IN the_DT presence_NN
          of_IN primer-dimer_JJ formations_NNS in_IN the_DT absence_NN of_IN a_DT template_NN ._.
          Nontemplate_NNP control_NN PCR_NNP reactions_NNS were_VBD always_RB run_VB in_IN
          triplicate_NN for_IN every_DT gene-specific_JJ reaction_NN mix_NN ._.
          Standard_JJ curves_NNS (_( cycle_NN threshold_NN values_NNS versus_CC
          template_NN concentration_NN )_) were_VBD prepared_VBN for_IN each_DT target_NN and_CC
          for_IN the_DT endogenous_JJ reference_NN (_( GAPDH_NNP )_) using_VBG cDNA_NN from_IN
          MDA-MB-_NNP 435_CD breast_NN cells_NNS as_IN the_DT calibrator_NN ._. For_IN each_DT
          experimental_JJ sample_NN ,_, the_DT amount_NN of_IN target_NN and_CC endogenous_JJ
          reference_NN were_VBD determined_VBN from_IN the_DT respective_JJ standard_JJ
          curves_NNS ,_, and_CC then_RB the_DT target_NN amount_NN was_VBD divided_VBN by_IN the_DT
          endogenous_JJ reference_NN amount_NN to_TO obtain_VB a_DT normalized_JJ target_NN
          value_NN ._. The_DT sequences_NNS of_IN the_DT PCR_NNP primer_NN pairs_NNS used_VBN for_IN
          each_DT gene_NN are_VBP as_IN follows_VBZ :_: TYRP-_NNP 1_CD ,_,
          5_CD '_POS -_: GATGGCAGAGATGATCGGGA-_NNP 3_CD '_POS and_CC
          5_CD '_POS -_: AGAAATTGCCGTTGCAGTGAC-_NNP 3_CD '_POS ;_: TSP-_NNP 1_CD ,_,
          5_CD '_POS -_: CAGCAGCCGCTTTTATGT-_NNP 3_CD '_POS and_CC 5_CD '_POS -_: CCGAGTATCCCT-GAGCCCTC-_NNP 3_CD '_POS
          ;_: OPN_NNP ,_, 5_CD '_POS -_: TTGCAGCCTTCTCAGCCAA-_NNP 3_CD '_POS and_CC
          5_CD '_POS -_: GGAGGCAAAAGCAAATCACTG-_NNP 3_CD '_POS ;_: and_CC GAPDH_NNP ,_,
          5_CD '_POS -_: CCACCCATGGCAAATTCC-_NNP 3_CD '_POS and_CC
          5_CD '_POS -_: GGGATTTCCATTGATGACA-_NNP 3_CD '_'' ._.
        
        
          Immunohistochemistry_NNP
          All_DT tissue_NN specimens_NNS (_( 68_CD frozen_VBN samples_NNS and_CC eight_CD FFPE_NNP
          samples_NNS )_) were_VBD evaluated_VBN immunohistochemically_RB ._. Monoclonal_NNP
          antibodies_NNS to_TO OPN_NNP ,_, to_TO TYRP-_NNP 1_CD and_CC to_TO TSP-_NNP 1_CD were_VBD purchased_VBN
          commercially_RB (_( OPN_NNP [_NN 1_CD :_: 100_CD ]_NN ,_, Chemicon_NNP International_NNP ,_, Inc_NNP ._. ,_,
          Temecula_NNP ,_, CA_NNP ,_, USA_NNP ;_: TYRP-_NNP 1_CD [_NN 1_CD :_: 80_CD ,_, clone_NN G-_NNP 17_CD ]_NN ,_, Santa_NNP Cruz_NNP
          Biotechnology_NNP ,_, Inc_NNP ._. ,_, CA_NNP ,_, USA_NNP ;_: TSP-_NNP 1_CD [_NN 1_CD :_: 320_CD ]_NN ,_, BD_NNP
          Transduction_NNP Laboratories_NNPS ,_, CA_NNP ,_, USA_NNP )_) ._. The_DT TYRP-_NNP 1_CD and_CC TSP-_NNP 1_CD
          antibody_NN reactions_NNS were_VBD optimized_JJ using_VBG the_DT DAKO_NNP LSAB_NNP
          plus_CC kit_NN (_( DAKO_NNP ,_, Carpinteria_NNP ,_, CA_NNP ,_, USA_NNP )_) for_IN both_DT frozen_VBN and_CC
          FFPE_NNP sections_NNS ._. The_DT monoclonal_NN rat_NN anti-human_JJ OPN_NNP antibody_NN
          was_VBD optimized_JJ using_VBG the_DT secondary_JJ biotinylated_JJ rabbit_NN
          anti-rat_JJ antibody_NN (_( 1_CD :_: 600_CD )_) and_CC streptavidin_NN /_NN horseradish_NN
          peroxidase_NN (_( 1_CD :_: 400_CD ;_: DAKO_NNP )_) ._. Primary_JJ tumors_NNS recovered_VBD from_IN
          nude_JJ mice_NNS inoculated_JJ with_IN the_DT M-_NNP 4_CD A_DT 4_CD and_CC NM-_NNP 2_CD C_NNP 5_CD MDA-MB-_NNP 435_CD
          clones_NNS [_NN 2_CD ]_NN were_VBD used_VBN as_IN positive_JJ controls_NNS ._.
          Tumor_NNP specimen_NN staining_VBG was_VBD scored_VBN as_IN positive_JJ or_CC
          negative_JJ ._. Positive_JJ staining_VBG was_VBD defined_VBN as_IN >_NN 50_CD %_NN of_IN the_DT
          tumor_NN cells_NNS or_CC the_DT benign_JJ epithelial_NN components_NNS examined_VBD
          having_VBG distinct_JJ cytoplasmic_JJ staining_VBG ._. The_DT four_CD additional_JJ
          FFPE_NNP archived_JJ ductal_NN carcinomas_NNS and_CC the_DT matched_VBN nodal_NN
          metastases_NNS (_( 
          n_NN =_SYM 8_CD )_) were_VBD stained_JJ with_IN the_DT
          aforementioned_JJ antibodies_NNS using_VBG the_DT antigen_NN retrieval_NN
          method_NN now_RB described_VBD to_TO assess_VB the_DT utility_NN of_IN the_DT
          antibodies_NNS on_IN archived_JJ tissues_NNS ._.
          Serial_JJ frozen_VBN sections_NNS were_VBD cut_VBN for_IN IHC_NNP and_CC for_IN
          LCM_NNP /_NN RT-qPCR_NNP for_IN concurrent_JJ analysis_NN ._. For_IN frozen_VBN tissues_NNS ,_,
          5_CD μm_NN cryostat_NN sections_NNS (_( Leica_NNP Microsystems_NNPS ,_, Heidelberger_NNP ,_,
          Germany_NNP )_) were_VBD briefly_NN fixed_VBN in_IN acetone_NN ._. Primary_JJ
          antibodies_NNS were_VBD incubated_JJ on_IN slides_NNS for_IN 1_CD hour_NN ._. After_IN
          several_JJ washings_NNS with_IN PBS_NNP ,_, secondary_JJ antibodies_NNS
          conjugated_JJ with_IN streptavidin_NN /_NN horseradish_NN peroxidase_NN were_VBD
          added_VBN for_IN 30_CD min-_NN 1_CD hour_NN ._. The_DT sections_NNS were_VBD washed_VBN and_CC
          stained_JJ with_IN 3_CD ,_, 3_CD '_POS -_: diaminobenzidine_NN (_( DAKO_NNP )_) for_IN 5_CD min_NN and_CC
          were_VBD then_RB counterstained_JJ with_IN Gills_NNP II_NNP hematoxylin_NN
          (_( Biochemical_NNP Sciences_NNPS ,_, Inc_NNP ._. ,_, Swedesboro_NNP ,_, NJ_NNP ,_, USA_NNP )_) ._.
          For_IN FFPE_NNP tissues_NNS ,_, 5_CD μm_NN sections_NNS were_VBD cut_VBN and_CC placed_VBN on_IN
          3_CD -_: aminopropyltriethoxysilane-coated_JJ slides_NNS ._. After_IN
          deparaffinization_NN ,_, the_DT endogenous_JJ peroxidase_NN was_VBD removed_VBN
          by_IN H_NNP 
          2_CD O_NNP 
          2_CD ._. Antigen_NNP retrieval_NN was_VBD performed_VBN by_IN
          steam_NN heating_NN for_IN 75_CD min_NN ._. After_IN sections_NNS were_VBD cooled_VBN to_TO
          room_NN temperature_NN ,_, the_DT background_NN staining_VBG was_VBD reduced_VBN by_IN
          incubation_NN of_IN serum_NN against_IN specific_JJ secondary_JJ antibody_NN ._.
          Slides_NNS were_VBD incubated_JJ with_IN primary_JJ antibodies_NNS for_IN 1_CD hour_NN ._.
          After_IN washing_VBG with_IN deionized_JJ water_NN and_CC PBS_NNP three_CD times_NNS ,_,
          species-specific_JJ secondary_JJ antibodies_NNS were_VBD added_VBN and_CC the_DT
          antibody_NN complex_NN was_VBD visualized_JJ by_IN 3_CD ,_, 3_CD '_POS -_: diaminobenzidine_NN ._.
          The_DT nuclei_NN were_VBD counterstained_JJ by_IN Gill_NNP 's_POS II_NNP
          hematoxylin_NN ._.
        
        
          Statistical_NNP analysis_NN
          All_DT statistical_JJ analyses_NNS used_VBD GraphPad_NNP Prism_NNP (_( GraphPad_NNP
          Software_NNP Inc_NNP ._. ,_, San_NNP Diego_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. Comparison_NNP of_IN
          numerical_JJ data_NNS was_VBD achieved_VBN using_VBG a_DT two-tailed_JJ unpaired_JJ 
          t_NN test_NN ._. 
          P_NN <_NN 0_CD ._. 05_CD was_VBD considered_VBN
          significant_JJ ._.
        
      
      
        Results_NNS
        
          Immunohistochemical_NNP detection_NN of_IN OPN_NNP ,_, TSP-_NNP 1_CD and_CC
          TYRP-_NNP 1_CD in_IN human_JJ breast_NN tissues_NNS
          The_DT efficacy_NN and_CC specificity_NN of_IN OPN_NNP ,_, TSP-_NNP 1_CD and_CC TYRP-_NNP 1_CD
          antibodies_NNS in_IN IHC_NNP was_VBD tested_VBN by_IN analysis_NN of_IN frozen_VBN tissue_NN
          xenografts_NNS of_IN known_VBN target_NN gene_NN expression_NN [_NN 2_CD 5_CD ]_NN ._.
          Positive_JJ cytoplasmic_JJ staining_VBG was_VBD detected_VBN with_IN the_DT OPN_NNP
          antibody_NN in_IN nine_CD of_IN 26_CD (_( 35_CD %_NN )_) primary_JJ breast_NN carcinomas_NNS
          with_IN nodal_NN metastases_NNS ._. A_DT representative_NN example_NN is_VBZ
          depicted_VBN in_IN Figure_NN 1_CD ._. Six_CD of_IN 26_CD (_( 23_CD %_NN )_) metastatic_JJ tissue_NN
          samples_NNS and_CC five_CD of_IN nine_CD (_( 56_CD %_NN )_) primary_JJ tumors_NNS without_IN
          metastases_NNS were_VBD OPN-positive_NNP ._. Incubation_NNP of_IN fibroadenoma_NN
          and_CC normal_JJ breast_NN tissue_NN specimens_NNS with_IN the_DT OPN_NNP antibody_NN
          also_RB produced_VBD positive_JJ staining_VBG in_IN the_DT epithelial_NN cells_NNS
          of_IN 53_CD %_NN of_IN nonmalignant_NN cases_NNS (_( five_CD fibroadenomas_NNS and_CC
          three_CD normal_JJ breast_NN tissues_NNS )_) ._. OPN_NNP was_VBD also_RB regularly_RB
          observed_VBD in_IN tumor-infiltrating_JJ inflammatory_JJ cells_NNS and_CC
          macrophages_NNS (_( Fig_NNP ._. 1_LS )_) ._. Although_IN difficult_JJ to_TO quantitate_NN ,_, a_DT
          trend_NN of_IN OPN_NNP localization_NN towards_IN the_DT epithelial_NN layer_NN
          but_CC not_RB the_DT myoepithelial_NN layer_NN was_VBD observed_VBN in_IN normal_JJ
          breast_NN tissue_NN (_( Fig_NNP ._. 1_LS )_) ._. Overall_RB ,_, the_DT degree_NN and_CC intensity_NN
          of_IN OPN_NNP expression_NN was_VBD qualitatively_RB equal_JJ in_IN samples_NNS of_IN
          adenomas_NNS ,_, adenocarcinomas_NNS and_CC nodal_NN metastases_NNS from_IN
          patients_NNS with_IN disseminated_VBN disease_NN ._. The_DT majority_NN of_IN
          primary_JJ carcinomas_NNS (_( 66_CD %_NN )_) that_WDT were_VBD positive_JJ for_IN OPN_NNP also_RB
          had_VBD concurrent_JJ OPN-positive_NNP metastases_NNS ._.
          IHC_NNP staining_VBG of_IN breast_NN tissue_NN sections_NNS revealed_VBD
          intracytoplasmic_JJ staining_VBG of_IN TSP-_NNP 1_CD in_IN six_CD of_IN 26_CD (_( 19_CD %_NN )_)
          node-positive_JJ primary_JJ carcinomas_NNS and_CC in_IN 10_CD of_IN 26_CD (_( 38_CD %_NN )_)
          metastases_NNS ._. In_IN this_DT case_NN ,_, all_DT positive_JJ primaries_NNS had_VBD
          positive_JJ associated_VBN metastases_NNS ,_, although_IN some_DT metastatic_JJ
          tumors_NNS with_IN positive_JJ TSP-_NNP 1_CD expression_NN had_VBD negative_JJ TSP-_NNP 1_CD
          stain_VB in_IN their_PRP$ primary_JJ tumors_NNS ._. TSP-_NNP 1_CD staining_VBG was_VBD
          positive_JJ in_IN two_CD of_IN nine_CD primary_JJ carcinomas_NNS without_IN
          metastases_NNS (_( 22_CD %_NN )_) ._. Very_RB weak_JJ staining_VBG was_VBD observed_VBN in_IN
          fibroadenoma_NN and_CC normal_JJ tissues_NNS ,_, and_CC no_DT TSP-_NNP 1_CD was_VBD
          detected_VBN in_IN breast_NN tissue_NN stromal_NN components_NNS ._.
          A_DT high_JJ percentage_NN of_IN node-positive_JJ primary_JJ tumors_NNS
          (_( 73_CD %_NN )_) ,_, metastatic_JJ carcinomas_NNS (_( 73_CD %_NN and_CC 100_CD %_NN concordance_NN
          between_IN primary_JJ tumor_NN and_CC associated_VBN metastasis_NNS ,_,
          respectively_RB )_) ,_, primary_JJ carcinomas_NNS without_IN metastases_NNS
          (_( 89_CD %_NN )_) ,_, benign_JJ breast_NN specimens_NNS (_( 70_CD %_NN )_) and_CC normal_JJ (_( 60_CD %_NN )_)
          breast_NN specimens_NNS were_VBD positive_JJ for_IN TYRP-_NNP 1_CD staining_VBG (_( Fig_NNP ._.
          1_LS )_) ._. TYRP-_NNP 1_CD staining_VBG was_VBD confined_VBN to_TO the_DT cytoplasm_NN and_CC to_TO
          the_DT epithelial_NN components_NNS of_IN the_DT tissue_NN ._. The_DT staining_VBG
          achieved_VBN with_IN all_DT three_CD antibodies_NNS was_VBD relatively_RB
          homogeneous_JJ across_IN the_DT tumor_NN in_IN positive_JJ cases_NNS ,_, and_CC no_DT
          qualitative_JJ differences_NNS in_IN staining_VBG were_VBD apparent_JJ at_IN the_DT
          invasive_JJ edge_NN of_IN the_DT carcinomas_NNS ._. No_DT correlation_NN was_VBD found_VBN
          between_IN protein_NN expression_NN and_CC tumor_NN grade_NN in_IN the_DT
          infiltrating_VBG ductal_NN carcinomas_NNS ,_, and_CC no_DT consistent_JJ
          qualitative_JJ differences_NNS were_VBD revealed_VBN between_IN primary_JJ
          tissues_NNS with_IN or_CC without_IN associated_VBN metastases_NNS ._.
        
        
          LCM_NNP and_CC qPCR_NN analysis_NN of_IN breast_NN tissues_NNS
          While_IN providing_VBG information_NN on_IN the_DT cellular_JJ
          distribution_NN of_IN target_NN gene_NN expression_NN ,_, the_DT technique_NN of_IN
          one-color_JJ chromogenic_JJ IHC_NNP staining_VBG can_MD result_VB in_IN highly_RB
          variable_JJ data_NNS across_IN samples_NNS ,_, and_CC it_PRP relies_VBZ on_IN visual_JJ
          '_POS scoring_VBG '_POS that_WDT is_VBZ relatively_RB subjective_JJ ._. To_TO obtain_VB
          accurate_JJ ,_, quantitative_JJ information_NN on_IN target_NN gene_NN
          expression_NN we_PRP employed_VBN qPCR_NN technology_NN ._. The_DT selection_NN of_IN
          specific_JJ cell_NN types_NNS from_IN the_DT heterogeneous_JJ cellular_JJ
          composition_NN of_IN the_DT tissue_NN specimens_NNS was_VBD attained_VBN by_IN LCM_NNP ._.
          This_DT procedure_NN allowed_VBD OPN_NNP ,_, TSP-_NNP 1_CD and_CC TYRP-_NNP 1_CD mRNA_NN
          analysis_NN in_IN specific_JJ cells_NNS of_IN interest_NN in_IN each_DT case_NN ,_,
          eliminating_VBG the_DT contribution_NN from_IN normal_JJ adjacent_JJ cells_NNS
          that_WDT could_MD cause_VB difficulties_NNS in_IN interpretation_NN ._.
          The_DT cells_NNS of_IN interest_NN in_IN the_DT majority_NN of_IN cases_NNS were_VBD
          those_DT of_IN epithelial_NN origin_NN ,_, but_CC eight_CD specimens_NNS were_VBD also_RB
          used_VBN for_IN the_DT isolation_NN of_IN tumor-associated_JJ stroma_NN
          (_( fibroblast_NN ,_, endothelial_NN and_CC inflammatory_JJ cells_NNS )_) for_IN
          comparison_NN ._. We_PRP measured_VBD the_DT expression_NN levels_NNS of_IN the_DT OPN_NNP ,_,
          TSP-_NNP 1_CD and_CC TYRP-_NNP 1_CD genes_NNS using_VBG a_DT quantitative_JJ PCR_NNP assay_NN
          (_( RT-qPCR_NNP )_) ._. This_DT analysis_NN ,_, in_IN line_NN with_IN the_DT findings_NNS of_IN
          the_DT IHC_NNP data_NN ,_, confirms_VBZ that_DT breast_NN tumor_NN cells_NNS themselves_PRP
          synthesize_VB OPN_NNP ,_, TSP-_NNP 1_CD and_CC TYRP-_NNP 1_CD (_( in_IN addition_NN to_TO
          tumor-infiltrating_JJ macrophages_NNS in_IN the_DT case_NN of_IN OPN_NNP )_) ._.
          Normal_NNP and_CC nonmalignant_NN breast_NN epithelia_NN and_CC stromal_NN
          elements_NNS expressed_VBD reduced_VBN levels_NNS of_IN OPN_NNP and_CC TYRP-_NNP 1_CD
          transcripts_NNS ._. Figures_NNS 2_CD ,_, 3_CD ,_, 4_CD demonstrate_VB the_DT differential_NN
          expression_NN pattern_NN and_CC the_DT quantitative_JJ expression_NN level_NN
          of_IN each_DT of_IN the_DT three_CD genes_NNS in_IN human_JJ breast_NN tissues_NNS ._.
          Relative_NNP to_TO the_DT GAPDH_NNP transcript_NN levels_NNS ,_, OPN_NNP expression_NN
          was_VBD found_VBN to_TO be_VB ~_NN 10_CD -_: fold_VB higher_JJR than_IN TYRP-_NNP 1_CD expression_NN in_IN
          all_DT tissues_NNS examined_VBD ._. TSP-_NNP 1_CD expression_NN was_VBD comparable_JJ
          with_IN that_DT of_IN TYRP-_NNP 1_CD in_IN malignant_JJ cells_NNS but_CC was_VBD at_IN the_DT
          limit_NN of_IN detection_NN in_IN normal_JJ and_CC benign_JJ epithelia_NN and_CC
          stromal_NN components_NNS ._.
          OPN_NNP mRNA_NN was_VBD found_VBN to_TO be_VB present_JJ in_IN all_DT microdissected_JJ
          tissue_NN samples_NNS examined_VBD ._. Significantly_RB elevated_VBD (_( ~_NN 5_CD -_: fold_VB )_)
          levels_NNS of_IN OPN_NNP transcripts_NNS were_VBD observed_VBN in_IN cells_NNS of_IN
          epithelial_NN origin_NN dissected_VBN from_IN primary_JJ carcinomas_NNS and_CC
          associated_VBN metastases_NNS over_IN nonmalignant_NN cell_NN sources_NNS ._. All_DT
          primary_JJ tumors_NNS combined_VBN (_( 
          P_NN =_SYM 0_CD ._. 017_CD )_) and_CC all_DT metastases_NNS (_( 
          P_NN =_SYM 0_CD ._. 0082_CD )_) exhibited_VBN significantly_RB
          elevated_VBD OPN_NNP expression_NN compared_VBN with_IN normal_JJ epithelia_NN
          (_( Fig_NNP ._. 2_LS )_) ._. However_RB ,_, there_EX was_VBD no_DT difference_NN in_IN OPN_NNP
          expression_NN between_IN primary_JJ carcinomas_NNS with_IN metastases_NNS and_CC
          those_DT without_IN metastases_NNS ._. Nor_CC was_VBD there_EX a_DT quantitative_JJ
          difference_NN in_IN OPN_NNP expression_NN between_IN primary_JJ carcinomas_NNS
          and_CC matched_VBN metastases_NNS (_( Fig_NNP ._. 2_LS )_) ._.
          While_IN trace_VB amounts_NNS were_VBD detected_VBN due_JJ to_TO the_DT
          sensitivity_NN of_IN PCR_NNP amplification_NN ,_, thrombospondin_NN
          transcripts_NNS were_VBD essentially_RB absent_JJ from_IN breast_NN tissue_NN
          epithelia_NN obtained_VBN from_IN normal_JJ and_CC benign_JJ specimens_NNS ,_, and_CC
          there_EX were_VBD no_DT appreciable_JJ levels_NNS detected_VBD in_IN stromal_NN
          tissue_NN components_NNS ._. However_RB ,_, TSP-_NNP 1_CD levels_NNS were_VBD
          significantly_RB raised_VBN in_IN malignant_JJ tissue_NN epithelial_NN
          sources_NNS (_( Fig_NNP ._. 3_LS )_) ._. TSP-_NNP 1_CD levels_NNS were_VBD significantly_RB higher_JJR
          (_( ~_NN 10_CD -_: fold_VB )_) in_IN all_DT primary_JJ tumors_NNS (_( 
          P_NN =_SYM 0_CD ._. 0017_CD )_) and_CC in_IN all_DT metastases_NNS (_(
          
          P_NN =_SYM 0_CD ._. 0001_CD )_) over_IN normal_JJ breast_NN
          epithelia_NN ._. In_IN line_NN with_IN the_DT OPN_NNP patterns_NNS of_IN expression_NN ,_,
          there_EX was_VBD no_DT significant_JJ difference_NN in_IN TSP-_NNP 1_CD levels_NNS
          between_IN primary_JJ tumors_NNS with_IN or_CC without_IN metastases_NNS ,_, nor_CC
          between_IN primary_JJ carcinomas_NNS and_CC associated_VBN metastases_NNS ._.
          TYRP-_NNP 1_CD expression_NN was_VBD higher_JJR than_IN that_DT of_IN TSP-_NNP 1_CD but_CC
          lower_JJR than_IN that_DT of_IN OPN_NNP (_( 10_CD -_: fold_VB to_TO 50_CD -_: fold_VB )_) ._. While_IN TYRP-_NNP 1_CD
          transcripts_NNS could_MD be_VB detected_VBN in_IN all_DT tissues_NNS examined_VBD
          (_( Fig_NNP ._. 4_LS )_) ,_, including_VBG malignant_JJ and_CC nonmalignant_NN sources_NNS ,_,
          there_EX were_VBD no_DT significant_JJ quantitative_JJ differences_NNS
          revealed_VBD between_IN the_DT types_NNS of_IN tissue_NN ._.
        
      
      
        Discussion_NNP
        A_DT greater_JJR understanding_NN of_IN the_DT molecular_JJ mechanisms_NNS
        involved_VBN in_IN metastatic_JJ spread_NN is_VBZ needed_VBN to_TO facilitate_VB
        advances_NNS in_IN prognostic_JJ evaluation_NN for_IN individual_JJ patients_NNS ,_,
        and_CC in_IN the_DT design_NN of_IN therapeutic_JJ interventions_NNS to_TO inhibit_VB
        the_DT process_NN ._. In_IN an_DT effort_NN to_TO establish_VB a_DT methodological_JJ
        framework_NN for_IN analysis_NN of_IN the_DT molecules_NNS and_CC the_DT mechanisms_NNS
        involved_VBN in_IN this_DT complex_JJ multistep_NN process_NN ,_, we_PRP previously_RB
        developed_VBD a_DT well-defined_JJ experimental_JJ system_NN in_IN which_WDT the_DT
        role_NN of_IN candidate_NN genes_NNS can_MD be_VB screened_VBD and_CC tested_VBN [_NN 2_CD ]_NN ._.
        By_IN serial_NN dilution_NN cloning_VBG of_IN the_DT MDA-MB-_NNP 435_CD tumor_NN cell_NN
        line_NN and_CC screening_NN by_IN orthotopic_JJ implantation_NN into_IN the_DT
        mammary_JJ fat_JJ pad_NN of_IN athymic_JJ mice_NNS ,_, we_PRP derived_VBD a_DT pair_NN of_IN
        breast_NN tumor_NN cell_NN lines_NNS (_( M-_NNP 4_CD A_DT 4_CD and_CC NM-_NNP 2_CD C_NNP 5_LS )_) that_WDT originate_VB
        from_IN the_DT same_JJ breast_NN tumor_NN ,_, but_CC that_WDT have_VBP diametrically_RB
        opposite_JJ metastatic_JJ capabilities_NNS ._. Through_IN multiple_JJ
        molecular_JJ analyses_NNS we_PRP have_VBP identified_VBN and_CC verified_VBN a_DT number_NN
        of_IN genes_NNS whose_WP$ expression_NN correlates_NNS with_IN the_DT metastatic_JJ
        phenotype_NN in_IN this_DT xenograft_NN model_NN ._. The_DT expression_NN of_IN the_DT
        proteins_NNS TSP-_NNP 1_CD and_CC TYRP-_NNP 1_CD were_VBD found_VBN to_TO correlate_VBP with_IN the_DT
        nonmetastatic_JJ phenotype_NN ,_, whereas_IN OPN_NNP was_VBD significantly_RB
        elevated_VBD in_IN the_DT metastatic_JJ counterpart_NN ._. These_DT findings_NNS
        prompted_VBD us_PRP to_TO investigate_VB the_DT occurrence_NN and_CC distribution_NN
        of_IN these_DT molecules_NNS in_IN human_JJ breast_NN tissues_NNS ._. The_DT
        investigative_JJ approach_NN was_VBD designed_VBN to_TO detect_VB and_CC quantify_VB
        the_DT three_CD molecules_NNS in_IN specific_JJ breast_NN tissue_NN components_NNS ,_,
        data_NNS that_WDT were_VBD not_RB previously_RB available_JJ ._.
        Having_VBG detected_VBN all_DT three_CD proteins_NNS immunohistochemically_RB
        in_IN normal_JJ ,_, benign_JJ and_CC malignant_JJ breast_NN epithelia_NN ,_, the_DT
        quantitation_NN of_IN OPN_NNP ,_, TSP-_NNP 1_CD and_CC TYRP-_NNP 1_CD mRNA_NN was_VBD achieved_VBN
        using_VBG LCM_NNP and_CC qPCR_NN ._. This_DT technique_NN allows_VBZ for_IN the_DT accurate_JJ
        procurement_NN of_IN cells_NNS from_IN specific_JJ microscopic_JJ regions_NNS of_IN
        tissue_NN sections_NNS ,_, and_CC therefore_RB enables_VBZ the_DT molecular_JJ
        genetic_JJ analysis_NN of_IN pure_JJ populations_NNS of_IN malignant_JJ breast_NN
        cells_NNS in_IN their_PRP$ native_JJ tissue_NN environment_NN [_NN 18_CD ]_NN ._. This_DT
        technical_JJ advance_NN helps_VBZ one_CD to_TO avoid_VB the_DT variation_NN and_CC
        subjectivity_NN associated_VBN with_IN IHC_NNP ,_, and_CC to_TO overcome_VB the_DT
        limitations_NNS of_IN data_NNS interpretation_NN caused_VBN by_IN tissue_NN
        heterogeneity_NN and_CC normal_JJ stromal_NN cell_NN contamination_NN in_IN
        homogenized_JJ tissue_NN specimens_NNS ._. Coupled_VBN with_IN qPCR_NN ,_, LCM_NNP can_MD
        reveal_VB significant_JJ differences_NNS in_IN specific_JJ gene_NN expression_NN
        that_WDT are_VBP not_RB accessible_JJ with_IN relatively_RB insensitive_JJ IHC_NNP
        alone_RB ._.
        We_PRP have_VBP demonstrated_VBN that_IN human_JJ breast_NN epithelia_NN can_MD
        themselves_PRP synthesize_VB OPN_NNP and_CC ,_, to_TO a_DT lesser_JJR extent_NN ,_, TSP-_NNP 1_CD
        and_CC TYRP-_NNP 1_CD 
        in_IN vivo_NN ,_, and_CC that_DT elevated_VBD OPN_NNP and_CC
        TSP-_NNP 1_CD levels_NNS are_VBP indicative_JJ of_IN malignancy_NN ._. Significant_JJ OPN_NNP
        expression_NN has_VBZ been_VBN reported_VBN in_IN a_DT number_NN of_IN breast_NN
        epithelial_NN cell_NN lines_NNS [_NN 19_CD 20_CD ]_NN ,_, and_CC so_IN it_PRP is_VBZ known_VBN that_IN
        cells_NNS of_IN breast_NN epithelial_NN origin_NN can_MD synthesize_VB OPN_NNP in_IN
        certain_JJ conditions_NNS ._. But_CC it_PRP is_VBZ possible_JJ that_IN 
        in_IN vitro_NN OPN_NNP expression_NN is_VBZ a_DT
        phenomenon_NN of_IN cell_NN culture_NN or_CC that_IN OPN-positive_NNP cells_NNS have_VBP
        a_DT selective_JJ growth_NN advantage_NN during_IN extended_VBN passage_NN ._.
        Synthesis_NNP of_IN OPN_NNP was_VBD also_RB observed_VBN in_IN infiltrating_VBG
        lymphocytes_NNS and_CC macrophages_NNS ,_, a_DT factor_NN that_WDT would_MD seriously_RB
        compromise_VB efforts_NNS to_TO quantify_VB OPN_NNP in_IN homogenized_JJ tissue_NN
        specimens_NNS ._. Such_JJ analysis_NN would_MD highlight_VB tumors_NNS with_IN a_DT high_JJ
        level_NN of_IN infiltrating_VBG inflammatory_JJ cells_NNS rather_RB than_IN
        evaluate_VB the_DT levels_NNS of_IN the_DT marker_NN molecule_NN (_( s_VBZ )_) in_IN the_DT
        proliferative_JJ epithelia_NN of_IN a_DT lesion_NN ._.
        As_IN observed_VBD in_IN IHC_NNP ,_, tumor-infiltrating_JJ inflammatory_JJ
        cells_NNS were_VBD presumably_RB the_DT stromal_NN source_NN of_IN OPN_NNP ._. Transcript_NNP
        levels_NNS in_IN normal_JJ and_CC fibroadenoma_NN epithelia_NN were_VBD equal_JJ to_TO
        those_DT found_VBD in_IN isolated_VBN stroma_NN ,_, indicating_VBG that_IN the_DT
        scattered_VBN infiltrating_VBG macrophages_NNS (_( not_RB lymphocytes_NNS )_) have_VBP
        relatively_RB high_JJ OPN_NNP expression_NN ._. The_DT presence_NN of_IN
        inflammatory_JJ infiltration_NN is_VBZ a_DT serious_JJ problem_NN in_IN the_DT
        molecular_JJ analysis_NN of_IN tissue_NN samples_NNS if_IN the_DT tissue_NN is_VBZ
        homogenized_JJ prior_RB to_TO analysis_NN ._. The_DT presence_NN of_IN OPN_NNP in_IN
        inflammatory_JJ cells_NNS highlights_VBZ the_DT advantage_NN of_IN
        microdissection_NN in_IN this_DT analytical_JJ context_NN ._.
        High_JJ levels_NNS of_IN OPN_NNP in_IN breast_NN tumor_NN cell_NN lines_NNS appear_VBP to_TO
        correlate_VBP with_IN a_DT more_RBR aggressive_JJ 
        in_IN vivo_NN phenotype_NN [_NN 2_CD 20_CD ]_NN ._.
        Transfection_NNP of_IN OPN_NNP expression_NN constructs_NNS into_IN cells_NNS
        producing_VBG noninvasive_JJ mammary_JJ epithelial_NN tumors_NNS has_VBZ been_VBN
        reported_VBN to_TO convert_VB them_PRP to_TO a_DT malignant_JJ phenotype_NN [_NN 8_CD 21_CD ]_NN
        ._. Furthermore_RB ,_, transfection_NN of_IN antisense_NN OPN_NNP constructs_NNS or_CC
        OPN-targeting_NNP ribozymes_NNS into_IN transformed_VBN tumorigenic_JJ cells_NNS
        can_MD result_VB in_IN impaired_VBN anchorage-independent_JJ growth_NN ,_, as_RB
        well_RB as_IN in_IN diminished_VBN tumor-forming_JJ ability_NN 
        in_IN vivo_NN [_NN 22_CD 23_CD ]_NN ._. OPN_NNP is_VBZ also_RB
        typically_RB overexpressed_JJ in_IN human_JJ tumors_NNS ,_, including_VBG breast_NN
        cancer_NN [_NN 15_CD 24_CD ]_NN ._. However_RB ,_, the_DT source_NN of_IN OPN_NNP in_IN primary_JJ
        breast_NN tumors_NNS was_VBD originally_RB thought_VBN to_TO be_VB infiltrating_VBG
        macrophages_NNS rather_RB than_IN tumor_NN cells_NNS themselves_PRP [_NN 15_CD ]_NN ._.
        By_IN applying_VBG 
        in_IN situ_NN hybridization_NN ,_, Tuck_NNP and_CC
        colleagues_NNS identified_VBD breast_NN tumor_NN cells_NNS as_IN a_DT source_NN of_IN OPN_NNP
        [_NN 13_CD ]_NN ._. Using_VBG a_DT semiquantitative_JJ scoring_VBG system_NN to_TO
        evaluate_VB immunohistochemical_JJ staining_VBG ,_, these_DT investigators_NNS
        found_VBD a_DT correlation_NN between_IN OPN_NNP positivity_NN (_( defined_VBN as_IN
        >_NN 33_CD %_NN of_IN tumor_NN cells_NNS in_IN a_DT section_NN staining_VBG for_IN OPN_NNP )_) in_IN
        lymph_NN node-negative_JJ primary_JJ breast_NN carcinomas_NNS and_CC patient_NN
        survival_NN ,_, suggesting_VBG that_IN tumor_NN cells_NNS with_IN elevated_VBD OPN_NNP
        levels_NNS may_MD behave_VB differently_RB with_IN regard_NN to_TO disease_NN
        progression_NN [_NN 13_CD ]_NN ._. Another_DT recent_JJ study_NN showed_VBD
        immunohistochemically_RB that_IN while_IN OPN_NNP protein_NN is_VBZ expressed_VBN
        weakly_RB in_IN normal_JJ breast_NN tissue_NN ,_, OPN_NNP is_VBZ expressed_VBN strongly_RB
        (_( >_NN 50_CD %_NN tumor_NN cell_NN staining_VBG )_) in_IN pregnant_JJ /_NN lactating_VBG tissue_NN
        and_CC in_IN the_DT majority_NN (_( 66_CD %_NN )_) of_IN breast_NN carcinomas_NNS ._. These_DT
        investigators_NNS also_RB found_VBD that_IN the_DT presence_NN of_IN OPN_NNP on_IN tumor_NN
        cells_NNS is_VBZ correlated_JJ with_IN patient_NN demise_NN [_NN 25_CD ]_NN ._.
        Our_PRP$ LCM-mediated_NNP transcript_NN detection_NN acts_NNS as_IN an_DT
        important_JJ confirmation_NN of_IN breast_NN tumor_NN cell_NN OPN_NNP synthesis_NN
        because_IN IHC_NNP analysis_NN does_VBZ not_RB rule_VB out_RP the_DT possibility_NN that_IN
        secreted_JJ proteins_NNS such_JJ as_IN OPN_NNP and_CC TSP-_NNP 1_CD are_VBP sequestered_VBN by_IN
        the_DT tumor_NN cells_NNS from_IN the_DT local_JJ environment_NN ._. Experiments_NNS
        with_IN cell_NN lines_NNS show_VBP that_IN tumor_NN cells_NNS can_MD bind_NN soluble_JJ OPN_NNP
        and_CC can_MD migrate_VB towards_IN an_DT OPN_NNP concentration_NN gradient_NN [_NN 8_CD
        19_CD ]_NN ;_: sequestration_NN from_IN the_DT extracellular_NN matrix_NN 
        in_IN vivo_NN is_VBZ thus_RB pertinent_JJ ._. In_IN the_DT
        present_JJ study_NN ,_, the_DT epithelial_NN layer_NN appeared_VBD to_TO express_VB
        more_JJR OPN_NNP than_IN the_DT myoepithelial_NN cells_NNS ,_, suggesting_VBG some_DT OPN_NNP
        accumulation_NN or_CC induction_NN via_IN the_DT myoepithelial_NN layer_NN or_CC
        via_IN stromal_NN interactions_NNS ._. Unfortunately_RB ,_, the_DT resolution_NN of_IN
        LCM_NNP does_VBZ not_RB enable_VB the_DT selection_NN of_IN epithelial_NN cells_NNS from_IN
        myoepithelial_NN cells_NNS and_CC so_IN we_PRP were_VBD unable_JJ to_TO confirm_VB this_DT
        quantitatively_RB ._.
        The_DT effect_NN of_IN TSP-_NNP 1_CD expression_NN on_IN tumor_NN growth_NN and_CC
        metastasis_NNS has_VBZ been_VBN examined_VBN 
        in_IN vivo_NN by_IN orthotopic_JJ inoculation_NN of_IN
        TSP-_NNP 1_CD -_: overexpressing_VBG MDA-MB-_NNP 435_CD cells_NNS ._. A_DT dose-dependent_JJ
        inhibition_NN of_IN spontaneous_JJ pulmonary_JJ metastases_NNS was_VBD
        reported_VBN ,_, but_CC this_DT was_VBD paralleled_JJ by_IN an_DT inhibition_NN of_IN
        primary_JJ tumor_NN growth_NN [_NN 26_CD ]_NN ._. TSP-_NNP 1_CD has_VBZ also_RB been_VBN
        implicated_VBN in_IN the_DT phenomenon_NN of_IN concomitant_NN tumor_NN
        resistance_NN ._. This_DT refers_VBZ to_TO the_DT ability_NN of_IN some_DT large_JJ
        primary_JJ tumors_NNS to_TO hold_VB smaller_JJR ,_, distant_JJ tumors_NNS in_IN check_NN ,_,
        preventing_VBG their_PRP$ progressive_JJ growth_NN ._. Volpert_NNP and_CC colleagues_NNS
        demonstrated_VBD this_DT phenomenon_NN using_VBG tumors_NNS formed_VBN by_IN the_DT
        human_JJ fibrosarcoma_NN line_NN HT_NNP 1080_CD in_IN nude_JJ mice_NNS ,_, and_CC obtained_VBD
        data_NNS indicating_VBG that_IN it_PRP was_VBD caused_VBN by_IN secretion_NN of_IN TSP-_NNP 1_CD by_IN
        the_DT primary_JJ tumor_NN [_NN 27_CD ]_NN ._. Some_DT of_IN the_DT properties_NNS
        attributed_VBD to_TO TSP-_NNP 1_CD are_VBP conflicting_JJ ,_, however_RB ;_: TSP-_NNP 1_CD can_MD be_VB
        both_DT adhesive_NN and_CC anti-adhesive_JJ 
        in_IN vitro_NN ,_, can_MD stimulate_VB or_CC inhibit_VB
        angiogenesis_NNS ,_, and_CC can_MD inhibit_VB or_CC enhance_VB proteolytic_JJ enzyme_NN
        activity_NN ._. The_DT composition_NN of_IN the_DT matrix_NN ,_, the_DT availability_NN
        of_IN cytokines_NNS and_CC proteases_NNS ,_, and_CC the_DT expression_NN of_IN various_JJ
        receptors_NNS in_IN a_DT given_VBN cellular_JJ environment_NN might_MD explain_VB
        these_DT opposing_VBG functions_NNS ._.
        Our_PRP$ findings_NNS in_IN the_DT MDA-MB-_NNP 435_CD metastasis_NNS model_NN are_VBP in_IN
        agreement_NN with_IN TSP-_NNP 1_CD playing_VBG a_DT role_NN in_IN the_DT reduction_NN of_IN
        metastatic_JJ potential_JJ [_NN 2_CD ]_NN ._. Clinically_NNP ,_, TSP-_NNP 1_CD expression_NN
        is_VBZ inversely_RB correlated_JJ with_IN tumor_NN grade_NN and_CC survival_NN rate_NN
        in_IN a_DT number_NN of_IN cancers_NNS [_NN 28_CD 29_CD ]_NN ,_, most_RBS probably_RB because_IN of_IN
        the_DT anti-angiogenic_JJ effect_NN of_IN TSP-_NNP 1_CD ._. A_DT recent_JJ study_NN
        confirms_VBZ this_DT to_TO be_VB the_DT case_NN in_IN breast_NN cancer_NN ,_, where_WRB
        expression_NN of_IN TSP-_NNP 1_CD in_IN stroma_NN adjacent_JJ to_TO ductal_NN carcinoma_NN 
        in_IN situ_NN is_VBZ lost_VBN in_IN cases_NNS with_IN more_RBR
        aggressive_JJ histological_JJ features_NNS [_NN 30_CD ]_NN ._. There_EX are_VBP also_RB
        reports_VBZ ,_, however_RB ,_, that_DT fibroblast_NN TSP-_NNP 1_CD can_MD induce_VB matrix_NN
        metalloproteinase-_NN 9_CD in_IN breast_NN tumor_NN cells_NNS and_CC gastric_JJ
        cancer_NN tumor_NN cells_NNS ,_, and_CC this_DT in_IN turn_NN may_MD lead_VB to_TO a_DT more_RBR
        invasive_JJ phenotype_NN [_NN 14_CD 31_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, TSP-_NNP 1_CD
        was_VBD not_RB expressed_VBN differentially_RB in_IN the_DT stroma_NN of_IN benign_JJ
        tissue_NN specimens_NNS or_CC malignant_JJ tissue_NN specimens_NNS ,_, nor_CC in_IN the_DT
        epithelial_NN component_NN of_IN breast_NN tumors_NNS with_IN or_CC without_IN
        metastases_NNS ._. The_DT increased_VBN levels_NNS observed_VBD in_IN malignant_JJ
        breast_NN epithelia_NN suggest_VBP a_DT shift_NN in_IN the_DT balance_NN between_IN the_DT
        anti-angiogenic_JJ and_CC proinvasive_JJ effects_NNS of_IN TSP-_NNP 1_CD during_IN
        tumor_NN progression_NN ._. The_DT precise_JJ biological_JJ role_NN of_IN TSP-_NNP 1_CD in_IN
        human_JJ tumor_NN progression_NN awaits_VBZ more_RBR definitive_JJ study_NN ._.
        In_IN the_DT present_JJ study_NN ,_, TYRP-_NNP 1_CD mRNA_NN was_VBD present_JJ ,_, but_CC at_IN
        very_RB low_JJ levels_NNS ,_, in_IN breast_NN tumor_NN tissue_NN ,_, in_IN associated_VBN
        stroma_NN and_CC in_IN normal_JJ breast_NN tissues_NNS ._. However_RB ,_, IHC_NNP reveals_VBZ
        that_IN TYRP-_NNP 1_CD protein_NN staining_VBG is_VBZ easily_RB detectable_JJ in_IN many_JJ
        samples_NNS ._. The_DT melanogenic_JJ enzymes_NNS tyrosinase_NN ,_, TYRP-_NNP 1_CD and_CC
        TYRP-_NNP 2_CD are_VBP well-characterized_JJ differentiation_NN antigens_NNS
        recognized_VBN by_IN antibodies_NNS and_CC T_NN cells_NNS of_IN patients_NNS with_IN
        melanoma_NN ._. TYRP-_NNP 1_CD is_VBZ a_DT type_NN I_PRP membrane_NN protein_NN expressed_VBN by_IN
        melanomas_NNS and_CC normal_JJ melanocytes_NNS that_WDT was_VBD originally_RB
        characterized_VBN as_IN an_DT oxidase_NN in_IN the_DT melanin_NN biosynthetic_JJ
        pathway_NN ._. Clinically_NNP ,_, TYRP-_NNP 1_CD is_VBZ thought_VBN to_TO be_VB important_JJ as_IN a_DT
        melanoma_NN antigen_NN that_WDT is_VBZ highly_RB antigenic_JJ to_TO cytotoxic_JJ T_NN
        cells_NNS ,_, providing_VBG a_DT potential_JJ target_NN for_IN melanoma_NN vaccine_NN
        development_NN [_NN 16_CD ]_NN ._. TYRP-_NNP 1_CD appears_VBZ to_TO be_VB less_JJR expressed_VBN in_IN
        advanced_VBD primary_JJ lesions_NNS and_CC metastases_NNS of_IN human_JJ cutaneous_JJ
        melanoma_NN and_CC uveal_NN melanoma_NN [_NN 32_CD ]_NN ._. Primary_JJ melanoma_NN
        samples_NNS express_VBP TYRP-_NNP 1_CD transcripts_NNS at_IN higher_JJR levels_NNS than_IN
        melanoma_NN metastases_NNS [_NN 33_CD ]_NN ,_, and_CC IHC_NNP analysis_NN of_IN malignant_JJ
        melanocytic_JJ lesions_NNS has_VBZ shown_VBN that_IN the_DT invasive_JJ cells_NNS of_IN
        primary_JJ melanomas_NNS are_VBP TYRP-_NNP 1_CD -_: negative_JJ [_NN 34_CD ]_NN ._.
        Our_PRP$ finding_VBG that_IN TYRP-_NNP 1_CD is_VBZ also_RB expressed_VBN in_IN the_DT poorly_RB
        metastatic_JJ or_CC noninvasive_JJ cell_NN lines_NNS NM-_NNP 2_CD C_NNP 5_CD [_NN 2_CD ]_NN ,_, T_NN 47_CD D_NNP ,_,
        MCF_NNP 7_CD and_CC DU_NNP 145_CD [_NN 5_CD ]_NN ,_, which_WDT are_VBP derived_VBN from_IN human_JJ breast_NN
        cancers_NNS and_CC prostate_NN tumors_NNS that_WDT are_VBP nonmetastatic_JJ ,_,
        indicates_VBZ that_IN this_DT molecule_NN is_VBZ not_RB exclusively_RB expressed_VBD
        in_IN cells_NNS of_IN the_DT melanocytic_JJ lineage_NN ._. It_PRP has_VBZ long_RB been_VBN known_VBN
        that_IN the_DT sera_NN of_IN patients_NNS who_WP suffer_VBP from_IN melanoma_NN or_CC
        mammary_JJ carcinoma_NN show_NN higher_JJR tyrosinase_NN activity_NN than_IN
        normal_JJ sera_NN [_NN 35_CD ]_NN but_CC ,_, to_TO our_PRP$ knowledge_NN ,_, this_DT is_VBZ the_DT first_JJ
        report_NN of_IN TYRP-_NNP 1_CD expression_NN in_IN human_JJ breast_NN duct_NN
        epithelium_NN ._. The_DT biological_JJ function_NN of_IN and_CC any_DT clinical_JJ
        significance_NN of_IN TYRP-_NNP 1_CD expression_NN in_IN normal_JJ or_CC malignant_JJ
        breast_NN carcinomas_NNS are_VBP presently_RB unknown_JJ ._.
      
      
        Conclusion_NNP
        We_PRP have_VBP quantitatively_RB analyzed_VBN transcripts_NNS of_IN OPN_NNP ,_, of_IN
        TSP-_NNP 1_CD and_CC of_IN TYRP-_NNP 1_CD in_IN microdissected_JJ human_JJ breast_NN tissues_NNS ._.
        Elevated_NNP levels_NNS of_IN OPN_NNP and_CC TSP-_NNP 1_CD expression_NN in_IN primary_JJ and_CC
        metastatic_JJ carcinomas_NNS suggest_VBP that_IN these_DT genes_NNS may_MD be_VB
        necessary_JJ for_IN ,_, but_CC not_RB sufficient_JJ for_IN ,_, dissemination_NN ._. Tumor_NNP
        cells_NNS that_WDT synthesize_VB matrix-associated_JJ factors_NNS such_JJ as_IN OPN_NNP
        and_CC TSP-_NNP 1_CD may_MD increase_VB their_PRP$ ability_NN to_TO independently_RB
        manipulate_VB their_PRP$ surroundings_NNS ,_, encouraging_VBG invasion_NN and_CC
        migration_NN ._. These_DT studies_NNS suggest_VBP that_IN the_DT quantitative_JJ
        analyses_NNS of_IN OPN_NNP and_CC /_NN or_CC TSP-_NNP 1_CD may_MD be_VB clinically_RB useful_JJ in_IN
        identifying_VBG malignant_JJ lesions_NNS over_IN benign_JJ lesions_NNS but_CC they_PRP
        are_VBP not_RB ,_, as_IN yet_RB ,_, promising_JJ markers_NNS for_IN the_DT evaluation_NN of_IN
        primary_JJ tumors_NNS for_IN metastatic_JJ propensity_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Abbreviations_NNP
        FFPE_NNP =_SYM formalin-fixed_JJ ,_, paraffin-embedded_JJ ;_: H_NNP &_CC E_NNP =_SYM
        hematoxylin_NN and_CC eosin_NN ;_: IHC_NNP =_SYM immunohistochemistry_NN ;_: LCM_NNP =_SYM
        laser_NN capture_NN microdissection_NN ;_: OPN_NNP =_SYM osteopontin_NN ;_: PBS_NNP =_SYM
        phosphate-buffered_JJ saline_NN ;_: PCR_NNP =_SYM polymerase_NN chain_NN reaction_NN ;_:
        qPCR_NN =_SYM real-time_JJ ,_, quantitative_JJ PCR_NNP ;_: RT_NNP =_SYM reverse_VB
        transcriptase_NN ;_: TSP-_NNP 1_CD =_SYM thrombospondin-_NN 1_CD ;_: TYRP-_NNP 1_CD =_SYM
        tyrosinase-related_JJ protein-_NN 1_CD ._.
      
    
  
